Next-Generation Sequencing: The Growth Moved. Did Your Sales Strategy Move With It?

by | Jul 1, 2026 | business development, Commercialization, CRM best practices, Data Management, Founders and Business Leaders, Fractional, Marketing, news, Sales

NGS isn’t “next gen” anymore. The core sequencing instrument market is dominated by a small number of established platform vendors, and that’s not changing. If your growth strategy still depends on competing for that instrument-level attention, you’re...

Lab Automation and Decentralized Labs: Your Customers’ Labs Changed. Has Your Pricing Model?

by | Jul 1, 2026 | Automation, business development, Commercialization, CRM best practices, Data Management, Founders and Business Leaders, news, Sales

Labs are getting smaller, more automated, and more distributed. Instruments are shrinking and handling more of the manual work themselves. Research hubs outside the traditional life science centers are standing up modular, flexible labs instead of building large...

Pharmacodynamic Biomarker Services: The Fastest Path to Revenue Isn’t the Biotech Sponsor

by | Jul 1, 2026 | business development, Commercialization, Founders and Business Leaders, Fractional, Marketing, news, Sales

Biomarker-guided drug development is now structural, not a passing trend; pharma and biotech companies rely on PD biomarkers to select doses, prove mechanism of action, and stratify patients across oncology, immunology, neurology, and rare disease. If you provide...